BioCentury
ARTICLE | Financial News

MEI raises $27.5 million

November 6, 2012 2:29 AM UTC

Cancer company MEI Pharma Inc. (NASDAQ:MEIP) raised $27.5 million through the sale of 55 million units at $0.50 in a private placement led by new investors Vivo Ventures and New Leaf Venture Partners. Institutional investors including RA Capital and Three Arch Opportunity also participated. Each unit comprises a share and a five-year warrant to purchase 0.7 shares, with each whole warrant exercisable at $0.52. Stifel Nicolaus Weisel was placement agent. Roth Capital Partners and Trout Capital were advisors. ...